Clinical Trials Browser

Completed × INDUSTRY × carotuximab × Clear all

NCT02560779 2020-07-17

Trial of TRC105 and Sorafenib in Patients With HCC

Phase 1/2 Completed

27 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03181308 2020-06-24

Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC

Phase 1 Completed

11 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT01975519 2020-05-20

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Phase 1/2 Completed

111 enrolled 15 charts

Hemangiosarcoma, Sarcoma

NCT02979899 2020-05-12

TAPPAS

Phase 3 Completed

128 enrolled 13 charts

Hemangiosarcoma

NCT03780010 2019-10-28

Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC

Phase 1 Completed

15 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT01564914 2019-06-12

105GM201

Phase 2 Completed

22 enrolled 11 charts

Glioblastoma

NCT02396511 2019-06-11

TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

Phase 2 Completed

2 enrolled 10 charts

Choriocarcinoma

NCT01326481 2019-03-18

TRC105

Phase 1/2 Completed

19 enrolled 9 charts

Breast Neoplasms

NCT01381861 2019-03-05

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Phase 2 Completed

23 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01332721 2018-12-05

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Phase 1 Completed

38 enrolled 8 charts

Other solid neoplasm

Adult Solid Tumor